Paper8013282
The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.
Fischer V and 6 others. Drug Metab Dispos, 1994. Cited by 90 papers, by iCite.
Cite this record
ConductScience Library. The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron. Papers, record 8013282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8013282
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytochrome P-450 Enzyme System | Major topic |
| Indoles | Major topic |
| Mixed Function Oxygenases | Major topic |
| Ondansetron | Major topic |
| Serotonin Antagonists | Major topic |
| Animals | |
| CHO Cells | |
| Cells, Cultured | |
| Chromatography, High Pressure Liquid | |
| Cricetinae | |
| Cyclosporine | |
| Cytochrome P-450 CYP2D6 | |
| Cytochrome P-450 Enzyme Inhibitors | |
| Humans | |
| Hydroxylation | |
| In Vitro Techniques | |
| Liver | |
| Microsomes, Liver | |
| Spectrometry, Mass, Fast Atom Bombardment | |
| Tropisetron |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41979467 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT3 Receptor Antagonists: 2026 Update. | Clin Pharmacol Ther | 2026 | https://conductscience.org/library/papers/41979467 | PubMed |
| 38882995 | Prevalence, Attributes, and Risk Factors of QT-Interval-Prolonging Drugs and Potential Drug-Drug Interactions in Cancer Patients: A Prospective Study in a Tertiary Care Hospital. | Cureus | 2024 | https://conductscience.org/library/papers/38882995 | PubMed |
| 37375836 | Pharmacogenetic Testing for the Pediatric Gastroenterologist: Actionable Drug-Gene Pairs to Know. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37375836 | PubMed |
| 37223851 | Simulation of drug-drug interactions between breast cancer chemotherapeutic agents and antiemetic drugs. | Daru | 2023 | https://conductscience.org/library/papers/37223851 | PubMed |
| 36597259 | CYP2D6 pharmacogenetics and phenoconversion in personalized medicine. | Expert Opin Drug Metab Toxicol | 2022 | https://conductscience.org/library/papers/36597259 | PubMed |
| 36350309 | Pediatric CYP2D6 metabolizer status and post-tonsillectomy nausea and vomiting after ondansetron. | Clin Transl Sci | 2023 | https://conductscience.org/library/papers/36350309 | PubMed |
| 36229874 | Experimentally designed electrochemical sensor for therapeutic drug monitoring of Ondansetron co-administered with chemotherapeutic drugs. | BMC Chem | 2022 | https://conductscience.org/library/papers/36229874 | PubMed |
| 35344639 | Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator. | CPT Pharmacometrics Syst Pharmacol | 2022 | https://conductscience.org/library/papers/35344639 | PubMed |
| 34670017 | Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series. | Clin Transl Sci | 2022 | https://conductscience.org/library/papers/34670017 | PubMed |
| 30672837 | PharmGKB summary: Ondansetron and tropisetron pathways, pharmacokinetics and pharmacodynamics. | Pharmacogenet Genomics | 2019 | https://conductscience.org/library/papers/30672837 | PubMed |
| 28002639 | Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron. | Clin Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28002639 | PubMed |
| 27988869 | Comparative Pharmacology and Guide to the Use of the Serotonin 5-HT3 Receptor Antagonists for Postoperative Nausea and Vomiting. | Drugs | 2016 | https://conductscience.org/library/papers/27988869 | PubMed |
| 23512709 | Does pharmacogenomics account for variability in control of acute chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists? | Curr Oncol Rep | 2013 | https://conductscience.org/library/papers/23512709 | PubMed |
| 19902987 | Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II. | Clin Pharmacokinet | 2009 | https://conductscience.org/library/papers/19902987 | PubMed |
| 19817501 | Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. | Clin Pharmacokinet | 2009 | https://conductscience.org/library/papers/19817501 | PubMed |
| 15740177 | Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same? | CNS Drugs | 2005 | https://conductscience.org/library/papers/15740177 | PubMed |
| 12799621 | Current position of 5HT3 antagonists and the additional value of NK1 antagonists; a new class of antiemetics. | Br J Cancer | 2003 | https://conductscience.org/library/papers/12799621 | PubMed |
| 12728290 | Effect of the CYP2D6 genotype on the pharmacokinetics of tropisetron in healthy Korean subjects. | Eur J Clin Pharmacol | 2003 | https://conductscience.org/library/papers/12728290 | PubMed |
| 10319191 | Polymorphic cytochromes P450 and drugs used in psychiatry. | Cell Mol Neurobiol | 1999 | https://conductscience.org/library/papers/10319191 | PubMed |
| 9723819 | Population pharmacokinetics of ondansetron: a covariate analysis. | Br J Clin Pharmacol | 1998 | https://conductscience.org/library/papers/9723819 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP2C19 | 1557 | PubTator's text mining | https://conductscience.org/library/genes/1557 | NCBI Gene |
| CYP2D6 | 1565 | PubTator's text mining | https://conductscience.org/library/genes/1565 | NCBI Gene |
| CYP2E1 | 1571 | PubTator's text mining | https://conductscience.org/library/genes/1571 | NCBI Gene |
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8013282
GET https://conductscience.org/api/papers/v1/8013282/cited_by?page=2